Merit Medical Systems, Inc.MMSI
Key ratios
Operating cash flow growth
18.1%TTM
2025
34.7%2024
52.1%2023
27.0%
EPS growth
23.2%TTM
2025
4.9%2024
25.3%2023
25.6%
FCF / Sales
12.9%TTM
2025
14.2%2024
13.7%2023
8.8%
Net margin
9.2%TTM
2025
8.5%2024
8.9%2023
7.5%
ROA
4.9%TTM
2025
4.8%2024
4.4%2023
4.2%
ROE
9.2%TTM
2025
8.7%2024
9.3%2023
8.1%
Revenue growth
10.2%TTM
2025
11.8%2024
7.9%2023
9.2%
Recent news
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
Track MMSI in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer